Healthtech Startups

Nalu Medical develops a non-integrated neurostimulation system that uses electrical impulses to interrupt pain signals for patients with intractable chronic nerve pain. The system consists of an implanted microstimulator, a separate electrode array, and an externally worn, battery-free therapy disc, offered as a drug-free treatment option to patients through their doctors.

9 investors

Nicoya provides digital biosensing instruments for biophysical characterization, enabling scientists to study molecular behavior and protein interactions in drug discovery and structural analysis. The company serves research institutions and biotech discovery teams with label-free binding kinetics, thermal shift screening, and hydrogen-deuterium exchange technologies.

9 investors

NiKang Therapeutics is a clinical-stage biotechnology company developing small molecule drugs for cancer, using structure-based drug design against targets such as HIF2α, CDK2, KRAS, and SHP2. It focuses on precision medicine for difficult-to-drug oncology targets, with three compounds advanced into first-in-human clinical testing.

9 investors

Noetik builds AI models to identify cancer patients most likely to respond to treatments and to discover new oncology drug targets. The platform aims to improve clinical trial patient selection and expand the set of viable cancer targets in drug development.

9 investors

Notable is an AI platform for healthcare organizations that uses AI agents to automate administrative and operational work across patient access, revenue cycle management, and care operations. It offers a low-code Flow Builder and in-platform Flow AI assistant to let teams create automations that reduce manual tasks, improve reimbursement, and close care gaps.

9 investors

Noyo builds APIs and infrastructure that connect and standardize benefits data, enabling modern benefits experiences to be embedded into software. It serves benefits technology providers and the health/employee benefits industry.

9 investors

9 investors

OrganOx develops the metra platform, a device that extends organ preservation time for liver transplants by maintaining continuous perfusion with oxygenated blood-based solutions, enabling surgeons to better assess organ viability and make more informed transplant decisions.

9 investors

Orion Sleep develops smart sleep technology, including sensors and covers, to make world-class sleep science accessible and affordable for consumers.

9 investors

OurRitual is a relationship health platform that combines licensed experts with AI to help couples navigate challenges and build stronger connections through personalized, continuous care. The platform delivers therapy-guided tools and support in everyday life for people seeking to strengthen their relationships.

9 investors

Oviva offers personalised dietary advice paired with a digital app to help people change eating habits and manage or prevent illness. It serves individuals looking to improve their health through targeted dietary changes.

9 investors

Paceline is a consumer app that connects to fitness and health devices and apps (such as Apple Health, Garmin, Oura, and WHOOP) to combine a user's activity and health data into a single score that measures consistency. Users earn Pacepoints for steady healthy habits and unlock rewards from partner brands that support healthy living.

9 investors

Particle Health provides secure healthcare data access and interoperability services, enabling analysis and actionable insights across healthcare platforms. The company serves healthcare innovators and providers seeking to break down data silos and improve patient care through technology-driven interoperability.

9 investors

Peppy provides employer-sponsored digital health support delivered by in-house clinicians across areas such as menopause, fertility, men's health, pregnancy and lifestyle care. It serves employers looking to offer specialised, evidence-based healthcare to their staff.

9 investors

Photon Health provides prescription routing infrastructure that lets patients choose a pharmacy based on real-time price, stock, and fulfillment options before a prescription is sent. It serves healthcare providers and clinical teams, aiming to reduce prescription transfers, abandonment, and staff callbacks.

9 investors

PhotoniCare develops OtoSight, an FDA-cleared optical coherence tomography device for non-invasive assessment and monitoring of middle ear infections in healthcare facilities. The technology is designed for physicians treating ear-related conditions and offers improved accuracy over traditional otoscope methods.

9 investors

Precision Neuroscience develops a minimally invasive, high-bandwidth brain-computer interface, including its Layer 7 cortical interface, initially aimed at helping people with paralysis control digital devices and robotics using their thoughts. The company works with hospital clinical partners on implanted studies and positions its technology as removable and upgradable without damaging the brain.

9 investors

Bluesight (formerly Protenus) provides AI-powered software for hospital pharmacy and compliance teams, covering RFID inventory tracking, drug diversion surveillance, purchasing optimization, 340B compliance, drug shortage management, and patient privacy monitoring. It integrates data from wholesalers, health records, dispensing cabinets, and HR systems to support pharmacy operations and executive analytics for health systems.

9 investors

Pulmocide is a biopharmaceutical company developing inhaled therapies for difficult-to-treat respiratory diseases, currently focused on respiratory fungal infections such as pulmonary aspergillosis. Its lead investigational drug, opelconazole, is an inhaled antifungal agent in Phase 3 trials for patients with invasive pulmonary aspergillosis not responding to standard care.

9 investors

Quit with Jones is a nicotine replacement therapy brand offering science-backed mints and digital support to help people quit smoking and vaping.

9 investors

Qvin develops the Q-Pad, an FDA-cleared diagnostic menstrual pad that collects menstrual blood samples for non-invasive health monitoring and disease diagnosis. The company uses biomarker analysis from menstrual fluid to serve healthcare organizations and diagnostic platforms in women's health diagnostics.

9 investors

Recuro is a virtual-first digital health platform that provides primary care, behavioral health, urgent care, and supplemental benefits (pharmacy, care management, advocacy) to patients, employers, health plans, and providers. The company delivers customizable virtual care solutions designed to improve access, member engagement, and health equity.

9 investors

Redesign Health is a venture capital and applied technology platform that builds and invests in next-generation healthcare companies using AI-native strategies. The firm partners with founders and existing businesses to develop solutions addressing healthcare system inefficiencies across prediction, personalization, and care delivery.

9 investors

Reema Health provides a personalized, community-based care model that connects people to health care and social support services in their local communities. It hires care team members directly from the communities it serves to help members access social safety net resources.

9 investors